Immunization Flashcards Preview

high yield concepts > Immunization > Flashcards

Flashcards in Immunization Deck (40)
Loading flashcards...
1
Q

National immunization Program

A

BCG
Monovalent Hep B
DPT-HiB-Hep B
OPV

2
Q

Bacillus Calmette Guerin (BCG)

A

Intradermally
Live attenuated

Given at the earliest possible age after birth
(first 2 months)

<12 months: 0.05 ml
>12 months: 0.1 ml

3
Q

Hepatitis B vaccine

A

Intramuscular

1st dose: birth or within 12 hours of life
minimum interval: 4 weeks
Final dose: not earlier than age 24 weeks

Another dose is needed if last dose >24 weeks

4
Q

Hepatitis B
Preterm
(mother: HBsAg (-) )

A

1st dose may be given at 30 days of age regardless of weight

Another dose of HBV is need for those <2 kgs whose 1st dose was received at birth

5
Q

Hep B vaccine
Preterm
(mother HBsAg (+)

A

administer HBV and HBIG (0.5ml) within 12 hours of life

HBIG should be administered not later than 7 days of age

6
Q

DPT

A

IM

minimum age: 6 weeks
minimum interval: 4 week

(6-10-14-16-20)
recommended interval between 3rd and 4th dose : 6 months, 4 months is valid)

5th dose may not be given if the 4th dose was administered at age 4 years or older

7
Q

HiB

A

IM

3 dose primary series
Minimum age: 6 weeks
minimum interval: 4 weeks

booster: given between 12-15 months with an interval of 6 months from the 3rd dose

8
Q

Poliovirus vaccine

A

OPV: per orem
IPV: IM

3 dose primary series

Minimum age: 6 weeks
Minimum interval: 4 week

A booster dose should be given on or after the 4th birthday and at least 6 months from the previous dose

9
Q

PCV

A

IM

minimum age: 6 weeks
3 doses with an interval of at least 4 weeks

booster given at 6 months after the 3rd dose

Healthy children 2 to 5 years who have no previous PCV vaccination may be given 1 dose of PCV13 or 2 doses of PCV 10 at least 8 weeks apart

Routine use of PCV is npt recommended for healthy children 5 years and above

10
Q

Rotavirus

A

PO

minimum age: 6 weeks
interval: 4 weeks

Last dose should be given not later than 32 weeks of age

11
Q

Monovalent human rotavirus vaccine 1 (RV1)

A

2 dose series

12
Q

Pentavalent bovine rotavirus vaccine (RV5)

A

3 dose series

13
Q

Influenza vaccine

A

Trivalent: IM or SC
Quadrivalent; IM

minimum age: 6 months

6 months - 35 months : 0.25 ml
36 months to 18 years: 0.5 ml

Children 6months to 8 years receiving influenza vaccine for the first time should receive 2 doses separated by at least 4 weeks. If only 1 dose was given , give 2 dose of the vaccine then 1 dose of vaccine thereafter

Children aged 9 - 18 years should receive 1 dose of vaccine yearly

14
Q

Measles vacine

A

Live attenuated
SC

age: 9 months but may be given as early as 6 month in cases of outbreaks

15
Q

Japanese Encephalitis

A

SC

age: 9 months
Children 9 months to 17 years of age should receive 1 primary dose followed by a booster 12-24 months after the primary dose

Individual 18 years and older should receive a single dose only

16
Q

MMR

A

SC
Live attenduated

minimum age: 12 months. may be given at early age if recommended by public health authorities
Minimum interval: 4 weeks

2 doses of MMR are recommended.
2nd dose: 4-6 years

Children below 12 months given any measles containing vaccine should be given 2 additional doses

17
Q

Varicella

A

SC
live attenuated

minimum age: 12 months
2 doses

1st dose: 12-15 months
2nd dose: 4-6 years

<13 years old: interval : 3 months. However id f the 2nd dose was administered at least 4 weeks after the first dose, it s considered valid

> 13 years old: 4 weeks interval

18
Q

MMRV

A

SC
Live attenuatad

minimum age: 12 months
Max age: 12 years
Minimum interval: 3 months

19
Q

Hepatitis A

A

IM
age: 12 months
2 dose
interval: 6 months

20
Q

Tdap

A

IM
* for children who are fully immunized, Td should be given every 10 years’

  • for fully immunized pregnant adolescent, 1 dose of tdap anytime after 20 weeks
  • Unimmunized pregnant adolescent, 3 dose Tdap (0,1,6 month) Tdap should replace one dose of Td given preferrably after 20 weeks of gestation
21
Q

HPV

A

IM
3 dose series

age: 9 years

Bivalent: 0,1,6 months
Quadrivalent: 0,2,6 months

Interval: 1 month then 3 months

Quadrivalent: can be given to males 9 to 18 years of age for the prevention of anogenital warts

22
Q

Rabies

A

IM or ID

IM: purified Vero cell Rabies Vaccine 9PVRV) 0.5 ml or Purified Chick Embryo cell Vaccine (PCEVC) 1 ml
0,7,21 or 28

ID: 0.1 ml on 0, 7, 21 or 28

23
Q

Typhoid vaccine

A

IM

age: 2 years olf with revaccination every 2-3 years

24
Q

Dengue vaccine

A
Live attenuated
SQ
age: 9 years
Max age: 45 years old
3 doses (0, 6,12)
25
Q

Cholera

A

PO
minimum age: 12 months
2 dose series (2 weeks apart)

26
Q

Meningococcal vaccine

A

Tetravalent menigococcal (ACYW-135) conjugate vaccine (MCV4-d, MCV4 TT, MCV4-CRM) given intramuscularly (IM)

Tetravalent menigococcal polysaccharide vaccine (MPS4) given IM or SC

Indicated for those at high risk for invasive disease: persistent complement component deficiencies, anatomic/functional asplenia, HIV

27
Q

MCV4-D

A

age: 9 months
9-23 months, 2 doses at 3months apart
2 years and above: 1 dose

Revaccinate: after 5 years

28
Q

MCV4-TT

A

children 12 months and above as single dose

Revaccinate: after 5 years

29
Q

MCV4-CRM

A

2 years and above as single dose

Revaccinate: after 5 years

30
Q

MPSV4

A

2 years and above as single dose

31
Q
Pneumococcal conjugate (PCV)
Pneumococcal Polysaccharide (PPSV)
A

IM

for children with high risk medical conditions (chronic heart, lung, kidney, DM, CSF leak, cochlear iplant, sickle cell, hemoglobinopatjies, asplenia, HIV)

2- 5 yearsL
1 dose of PCV13 if an incomplete 3 dose of PCV
2 dose of PCV13 at least 8 weeks apart
Give supplemental dose of PCV13 if 4 doses of PCV7 or other series was given

For children with no histor of PPSV vaccination; give PPSV at least 8 weeks after the most recent PCV13

6-18 years:
1 dose of PCV13 followed by 1 dose of PPSV atleast 8 weeks
1 dose of PPSV at least 8 weeks after the most recnt PCV 13 if the precious PCV13 but s PPSV immunization
single dose of PPSV at least 8 weeks after the last dose of PCV13 in children with no history of PPSV immunization

32
Q

HiB

A

IM

12-59 months:

  • Unimmunized or wit 1 dose of Hib before age of 12 (GIVE ADDITIONAL 2 DOSES 8 WEEKS APART)
  • Give >2 doses of Hib before age of 12 months, (GIVE 1 ADDITIONAL DOSE)
33
Q

Viral Live Attenuated Vaccines

A
MMR
Varicerlla
Yellow Fever
Rotavirus
OPV
Intranasal influenza
34
Q

Bacterial LIve Attenuated

A

BCG

35
Q

Viral Inactivated

A

Polio
Hep A
Rabies
Influenza

36
Q

Bacterial Inactivated

A

Pertussis, Typhoid, Cholera

37
Q

Sub-unit Inactivated

A
Hep B
Influenza
Acellular Pertussis
HPV
Lyme
38
Q

Toxoid Inactivated

A

Diptheria

Tetanus

39
Q

Pure Polyssacharide Vaccines

A

Pneumococcal
Meningococcal
S. Typhi (Vi)

40
Q

Conjugate Polysaccharide Vaccines

A

Pneumococcal, Meningococcal, Hib